Cerivastatin prevents angiotensin II-induced renal injury independent of blood pressure- and cholesterol-lowering effects
- 1 October 2000
- journal article
- Published by Elsevier BV in Kidney International
- Vol. 58 (4), 1420-1430
- https://doi.org/10.1046/j.1523-1755.2000.00304.x
Abstract
No abstract availableThis publication has 39 references indexed in Scilit:
- Blood Pressure–Independent Effects in Rats With Human Renin and Angiotensinogen GenesHypertension, 2000
- Cyclosporin A Protects Against Angiotensin II–Induced End-Organ Damage in Double Transgenic Rats Harboring Human Renin and Angiotensinogen GenesHypertension, 2000
- Recent advances in statins and the kidneyKidney International, 1999
- Additional reduction in blood pressure after cholesterol-lowering treatment by statins (lovastatin or pravastatin) in hypercholesterolemic patients using angiotensin-converting enzyme inhibitors (enalapril or lisinopril)The American Journal of Cardiology, 1999
- Monocyte Infiltration and Adhesion Molecules in a Rat Model of High Human Renin HypertensionHypertension, 1999
- Hypertension-Induced End-Organ DamageHypertension, 1999
- Effects of the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors, atorvastatin and simvastatin, on the expression of endothelin-1 and endothelial nitric oxide synthase in vascular endothelial cells.JCI Insight, 1998
- High Human Renin Hypertension in Transgenic RatsHypertension, 1997
- Human mesangial cell production of monocyte chemoattractant protein-1: Modulation by lovastatinKidney International, 1995
- Hypertension and the Pathogenesis of AtherosclerosisHypertension, 1995